Net profit of Orchid Pharma rose 37.58% to Rs 27.24 crore in the quarter ended September 2024 as against Rs 19.80 crore during the previous quarter ended September 2023. Sales rose 12.04% to Rs 222.70 crore in the quarter ended September 2024 as against Rs 198.76 crore during the previous quarter ended September 2023.
Particulars | Quarter Ended |
| Sep. 2024 | Sep. 2023 | % Var. |
Sales | 222.70 | 198.76 | 12 |
OPM % | 13.62 | 11.73 | - |
PBDT | 34.53 | 27.86 | 24 |
PBT | 25.90 | 20.02 | 29 |
NP | 27.24 | 19.80 | 38 |